Smallpox pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
* [[Bone marrow]]
* [[Bone marrow]]


* [[Kidneys]]  
* [[Kidneys]]
 
The immune system responds to the viremia with activation of lymphocytes T and B, with concomitant production of:<ref name="BremanHenderson2002">{{cite journal|last1=Breman|first1=Joel G.|last2=Henderson|first2=D.A.|title=Diagnosis and Management of Smallpox|journal=New England Journal of Medicine|volume=346|issue=17|year=2002|pages=1300–1308|issn=0028-4793|doi=10.1056/NEJMra020025}}</ref>
 
* Neutralizing antibodies,during first week of disease
* Hemagglutination-inhibition antibodies, by the 16th day of infection
* Complement-fixation antibodies, by the 18th day of infection


==Associated Conditions==
==Associated Conditions==

Revision as of 20:57, 9 July 2014

Smallpox Microchapters

Home

Patient Information

Overview

Historical Perspective

Eradication
Post-Eradication

Pathophysiology

Causes

Differentiating Smallpox from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Outbreak Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case Studies

Smallpox pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Smallpox pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Smallpox pathophysiology

CDC on Smallpox pathophysiology

Smallpox pathophysiology in the news

Blogs on Smallpox pathophysiology

Directions to Hospitals Treating Smallpox

Risk calculators and risk factors for Smallpox pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Transmission

Smallpox virus is transmitted by:[1]

Genetics

Pathogenesis

The smallpox virus commonly enters the body through the upper respiratory tract, invading the oropharyngeal and respiratory mucosa.[2] Other possible ports of entry include: skin, conjunctivae as well as through the placenta.[3] Although the viral scabs may contain life viruses, they are commonly contained within thickened material, which limits transmissibility.

Once in the respiratory mucosa, the infection commonly progresses as:[4][3][5]

During secondary viraemia the virus infects mucous cells of the pharynx and mouth, and endothelium of the capillaries of the dermis, causing skin scabs. Other organs with high viral loads include:[5]

The immune system responds to the viremia with activation of lymphocytes T and B, with concomitant production of:[5]

  • Neutralizing antibodies,during first week of disease
  • Hemagglutination-inhibition antibodies, by the 16th day of infection
  • Complement-fixation antibodies, by the 18th day of infection

Associated Conditions

Gross Pathology

Microscopic Pathology

References

  1. "Smallpox disease overview".
  2. Cecil, Russell (2012). Goldman's Cecil medicine. Philadelphia: Elsevier/Saunders. ISBN 1437716040.
  3. 3.0 3.1 "Smallpox and its Eradication" (PDF).
  4. Moore, Zack S; Seward, Jane F; Lane, J Michael (2006). "Smallpox". The Lancet. 367 (9508): 425–435. doi:10.1016/S0140-6736(06)68143-9. ISSN 0140-6736.
  5. 5.0 5.1 5.2 Breman, Joel G.; Henderson, D.A. (2002). "Diagnosis and Management of Smallpox". New England Journal of Medicine. 346 (17): 1300–1308. doi:10.1056/NEJMra020025. ISSN 0028-4793.

Template:WH Template:WS